At Cambridge Molecular Diagnostics Limited, we’re proud to announce the launch of a new lateral flow test for the detection of Mycoplasma contamination. This innovative, easy-to-use and rapid test for the detection of mycoplasma utilises an adapted PCR method and provides accurate results within minutes, making it a valuable tool for laboratories and manufacturers in academia and the biotech and pharmaceutical industries. The test has been fully validated, including evaluation within the University of Cambridge.
Mycoplasma are small, parasitic bacteria, and contamination is a common problem in cell culture, leading to inaccurate research results and costly delays in product development. Traditional methods for testing for detecting Mycoplasma, such as qPCR and culture, can take several days to yield results. Our new lateral flow test, the Mycoplasma Detection Kit, offers a faster and more convenient solution.
The SwiftDx Mycoplasma Detection Kit uses a small sample taken directly from the cell culture media supernatant, with no interruption of cell growth, and provides results in a simple, easy-to-read format. The test is highly sensitive and specific, with a detection limit of less than 10 cfu/mL after day 3 of culture. It is time and cost-effective, making it a valuable addition to any laboratory’s Mycoplasma detection arsenal. This new test will be a valuable tool for researchers and biomanufacturers to ensure the quality and integrity of their cell culture systems, and ultimately improve the reproducibility of their research.
“We are thrilled to offer this innovative test to our customers,” said Professor Denis Kinane, Chairman at Cambridge Molecular Diagnostics Limited. “Mycoplasma contamination is a major concern in the biotech and pharmaceutical industries, and the SwiftDx Mycoplasma Detection Kit provides a fast, accurate and cost-effective solution. We believe that the convenience and speed of the SwiftDx Mycoplasma Detection Kit is game-changing for anyone using cell culture, from academic institutions to vaccine manufacturers. This product will help these organisations to stop mycoplasma contamination in its tracks.”
The SwiftDx Mycoplasma Detection Kit is available now and can be ordered through our website, or by contacting our team directly.